業績

2014年

  1. Manabe S, Banno M, Nakano M, Fujii T, Fujiwara M, Kita Y, Nitta K, Hatano M. Bucillamine-induced membranous nephropathy with crescent formation in a patient with rheumatoid arthritis: case report and literature review. Case Rep Nephrol Dial. 2014 Oct 29;5(1):30-8.
  2. Komatsu M, Okazaki M, Tsuchiya K, Kawaguchi H, Nitta K. Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients. Kidney Blood Press Res. 2014;39(6):658-67.
  3. Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Medicine (Baltimore). Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. 2014 Dec;93(29):e300.
  4. Nitta K, Nagano N, Tsuchiya K.　Fibroblast growth factor 23/klotho axis in chronic kidney disease.　 Nephron Clin Pract. 2014;128(1-2):1-10.
  5. Nitta K.　Message from the new president of the Japanese Society for Dialysis Therapy.　 Ther Apher Dial. 2014 Oct;18(5):373-4.
  6. Okada K, Yanai M, Takeuchi K, Matsuyama K, Nitta K, Hayashi K, Takahashi S. Sex differences in the prevalence, progression, and improvement of chronic kidney disease.　 Kidney Blood Press Res. 2014;39(4):279-88.
  7. Kikuchi K, Akiba T, Nitta K, Masakane I, Ando R, Izumi N, Atsukawa M, Yamazaki C, Kato F, Hotta N, Tominaga Y, Orito E, Hora K, Nagasawa M, Kasahara H, Kawaguchi M, Kimura H, Ikebe N, Kawanishi H, Moriishi M, Shigemoto K, Harada T, Hirakata H, Watanabe H, Nosaki T, Tsubouchi H, Imawari M, Akizawa T. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study. Ther Apher Dial. 2014 Dec;18(6):603-11.
  8. Tsuruta Y, Mochizuki T, Moriyama T, Itabashi M, Takei T, Tsuchiya K, Nitta K. Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol. 2014 Nov;33(11):1643-8.
  9. Ando K, Nitta K, Rakugi H, Nishizawa Y, Yokoyama H, Nakanishi T, Kashihara N, Tomita K, Nangaku M, Takahashi K, Isshiki M, Shimosawa T, Fujita T.Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) study. Int J Med Sci. 2014 Jun 21;11(9):897-904.
  10. Manabe S, Oshima Y, Nakano M, Fujii T, Maehara T, Nitta K, Hatano M. Renal infarction in a patient with pulmonary vein thrombosis after left upper lobectomy. Case Rep Nephrol Urol. 2014 May 22;4(2):103-8.
  11. Tsuruta Y, Nitta K, Akizawa T, Fukuhara S, Saito A, Karaboyas A, Li Y, Port FK, Robinson BM, Pisoni RL, Akiba T. Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS. Int Urol Nephrol. 2014 Sep;46(9):1833-41.
  12. Hara M, Ando M, Maeda Y, Tsuchiya K, Nitta K. Proteinuria is a simple sign of systemic inflammation that leads to a poor prognosis in individuals affected with non-Hodgkin lymphoma. Clin Nephrol. 2014 Jul;82(1):51-7.
  13. Shiohira S, Yoshida T, Sugiura H, Nishida M, Nitta K, Tsuchiya K. Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis. Physiol Rep. 2013 Dec 5;1(7):e00172.
  14. Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014 Mar 21;9(3):e91756.
  15. Okazaki M, Komatsu M, Kawaguchi H, Tsuchiya K, Nitta K. Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients. Blood Purif. 2014;37(2):106-12.
  16. Moriyama T, Oshima Y, Tanaka K, Iwasaki C, Ochi A, Itabashi M, Takei T, Uchida K, Nitta K. Statins stabilize the renal function of IgA nephropathy. Ren Fail. 2014 Apr;36(3):356-60.
  17. Itabashi M, Takei T, Moriyama T, Shiohira S, Shimizu A, Tsuruta Y, Uchida K, Nitta K. Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index. Mod Rheumatol. 2014 Jan;24(1):112-9.
  18. Yanagisawa N, Muramatsu T, Yamamoto Y, Tsuchiya K, Nitta K, Ajisawa A, Fukutake K, Ando M. Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate. Clin Exp Nephrol. 2014 Aug;18(4):600-5.
  19. Miyaoka T, Mochizuki T, Takei T, Tsuchiya K, Nitta K. Serum uric acid levels and long-term outcomes in chronic kidney disease. Heart Vessels. 2014 Jul;29(4):504-12.
  20. Ogawa T, Shimizu H, Kyono A, Sato M, Yamashita T, Otsuka K, Nitta K. Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study. Int Urol Nephrol. 2014 Jan;46(1):151-9.
  21. Kamei D, Moriyama T, Takei T, Wakai S, Nitta K. Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. Clin Exp Nephrol. 2014 Apr;18(2):320-8.
  22. Sugimoto H, Ogawa T, Iwabuchi Y, Otsuka K, Nitta K. Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients. Int Urol Nephrol. 2014 Jan;46(1):99-106.
  23. Hara M, Tsuchiya K, Nitta K, Ando M. Measurements of procalcitonin facilitate targeting of endotoxin adsorption treatment in febrile neutropenic patients suffering from shock. Clin Nephrol. 2014 Jan;81(1):67-70.